Embedded Files
February 27, 2023 1-4:30pm (PST)
Roth Auditorium at Sanford Consortium for Regenerative Medicine
2880 Torrey Pines Scenic Drive, La Jolla, CA 92037
On-demand streaming will be available at a later date.
Registration is required if you wish to watch on-demand streaming.
Start-ups stemming from academia who have state-of-the-art innovations with solid science and technologies will participate the event, and present their novel technologies and seeds in the life science fields including pharmaceuticals, regenerative medicine, medical devices, and diagnostics. Participants who are interested in investing on medical area innovations will be welcomed.
Registration fee : Free
contact : info@kurcsd.com
Program
* 6 minutes for presentation, 4 minutes for comments & Q/A .
* The program is subject to change.
1:00pm(PST) Opening remarks
1:05pm(PST) Showcase 1 & 2
2:25pm(PST) Break
2:45pm(PST) Showcase 3 & 4
4:30pm(PST) Networking & reception
6:00pm(PST) Adjourn
Showcase 1 - Immunology & Antibodies
"Antibody-drug conjugates (ADCs) for recurrent and refractory cancers"
BFACT Co., Ltd.
info@bfact.co.jp
"MiraBiologics Overcomes the boundary of Biologics"
MiraBiologics Inc.
contact@mirabiologics.com
"Pioneering Innovations to Dial Immunity"
Autoimmunity BioSolutions
gaddiel@abstherapeutics.com
Showcase 2 - Medical deivce & Diagnosis
"Embryo evaluation service by non-invasive determination of chromosomal aneuploidy using AI"
NextGeM Inc.
isao.miyatsuka@nextgem.jp
"AI-Infection Detector: a Medical Device Approved and Reimbursed in Japan, Seeking for Opportunity in the US/FDA"
Aillis, Inc.
sho.okiyama@aillis.jp
"Combating antimicrobial resistance problem with diagnostic support AI and point-of-care automatic device"
CarbGem Inc.
yang.luda@carbgem.com
"Total IVD solution using microarray technology enabling onsite diagnoses"
R-NanoBio Co., Ltd.
y-ito@r-nanobio.co.jp
Showcase 3 - Cell therapy
"Exosome as a DDS for Nucleic Acid Medicines"
PROGENICYTE JAPAN Co,Ltd
ksugaya@progenicytejapan.com
"Novel stem cell treatment to restore neuronal function and patients’ QOLs"
Oligogen, Inc.
info@oligogen.jp
"Device for rapid non-enzymatic stem cell separation from adipose tissue"
Synova Life Sciences
jchi@synovalife.com
"Pioneering a New Era of Treating Cancer"
Rebirthel Co., Ltd.
m.kajikawa@rebirthel.com
Showcase 4 - Small molecules & Oligonucleotides
"Novel, non-addictive, extra-strength oral painkiller as a solution for the opioid crisis"
BTB Drug Development Research Center
info@btb-newdrug.co.jp
"Next-gen Smart mRNA Therapy with RNA Switch"
aceRNA Technologies Co., Ltd.
f-sugawa@acernatec.com
"Xenoligo®DNA Aptamers: New Frontier in oligonucleotide aptamer-based Therapies"
TAGCyx biotechnologies Inc.
kudose@tagcyx.com
Commentators
Sanjay V Malhotra, PhD
Professor, Cell, Developmental & Cancer Biology, Director of Center for Experimental Therapeutics, OHSU
Jay Kunin, Ph.D.
Adjunct Professor of University of San Diego, Boards of PharmaSecure, Inc. and Sironis, Inc
Rieko Yajima, Ph.D.
Director, Drug Discovery Innovation SPARK Program in Translational Research, Stanford University
Stephen Mon Wei Chang, Ph.D.
Chair of the Board of Directors, Histogen, Inc.
Sponsors
Report abuse